Johan Verbeeck (J Verbeeck)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Topics

Liquid Chromatography

Skeletal Muscle

Respiratory Syndrome Coronavirus

Top Venues

Statistics in medicine

European heart journal. Acute cardiovascular care

Pharmaceutical statistics

This page only lists publications with an associated author ORCID identifier.

Publications

Johan Verbeeck, E D Saad
Rethinking Survival Analysis: Advancing Beyond the Hazard Ratio? European heart journal. Acute cardiovascular care (2024)
Johan Verbeeck
Enhancing robustness in acute cardiovascular observational studies: evaluating covariate adjustment. European heart journal. Acute cardiovascular care 13 (7) (2024)
Stijn Jaspers, Johan Verbeeck, Olivier Thas
Covariate-adjusted generalized pairwise comparisons in small samples. Statistics in medicine 43 (21) (2024)
Johan Verbeeck
Enhancing Robustness in Acute Cardiovascular Observational Studies: Evaluating Covariate Adjustment. European heart journal. Acute cardiovascular care (2024)
Maxime Fajgenblat, Geert Molenberghs, Johan Verbeeck, Lander Willem, Jonas Crèvecoeur, Christel Faes, Niel Hens, Patrick Deboosere, Geert Verbeke, Thomas Neyens
Evaluating the direct effect of vaccination and non-pharmaceutical interventions during the COVID-19 pandemic in Europe. Communications medicine 4 (1) (2024)
Stijn Jaspers, Johan Verbeeck, Olivier Thas
Covariate-adjusted generalized pairwise comparisons in small samples. Statistics in medicine (2024)
Stijn Jaspers, Johan Verbeeck, Olivier Thas
Covariate-adjusted generalized pairwise comparisons in small samples. Statistics in medicine 43 (21) (2024)
Johan Verbeeck, Everardo D Saad
Rethinking survival analysis: advancing beyond the hazard ratio? European heart journal. Acute cardiovascular care 13 (3) (2024)
Johan Verbeeck, Martin Geroldinger, Konstantin Thiel, Andrew Craig Hooker, Sebastian Ueckert, Mats Karlsson, Arne Cornelius Bathke, Johann Wolfgang Bauer, Geert Molenberghs, Georg Zimmermann
How to analyze continuous and discrete repeated measures in small-sample cross-over trials? Biometrics (2023)
Godelieve J M Vandersmissen, Johan Verbeeck, P Henckens, J Van Dyck, C Wuytens, G Molenberghs, L Godderis
Sick leave due to SARS-CoV-2 infection. Occupational medicine (Oxford, England) (2023)
Johan Verbeeck, Maya Dirani, Johann W Bauer, Ralf-Dieter Hilgers, Geert Molenberghs, Rima Nabbout
Composite endpoints, including patient reported outcomes, in rare diseases. Orphanet journal of rare diseases 18 (1) (2023)
James Song, Johan Verbeeck, Bo Huang, David C Hoaglin, Margaret Gamalo, Yodit Seifu, Duo-Lao Wang, Freda Cooner, Gaohong Dong
The win odds: statistical inference and regression. Journal of biopharmaceutical statistics (2022)
Florian Stijven, Johan Verbeeck, Geert Molenberghs
Comparing COVID-19 incidences longitudinally per economic sector against the background of preventive measures and vaccination. Biometrics (2022)
Patrick L S van Dun, Johan Verbeeck, Lorenzo Arcuri, Jorge E Esteves, Francesco Cerritelli
The Profile of Belgian Osteopaths: A Cross-Sectional Survey. Healthcare (Basel, Switzerland) 10 (11) (2022)
Gaohong Dong, Bo Huang, Johan Verbeeck, Ying Cui, James Song, Margaret Gamalo, Duolao Wang, David C Hoaglin, Yodit Seifu, Tobias Mütze, John Kolassa
Win statistics (win ratio, win odds, and net benefit) can complement one another to show the strength of the treatment effect on time-to-event outcomes. Pharmaceutical statistics (2022)
Johan Verbeeck, Godelieve Vandersmissen, Jannes Peeters, Sofieke Klamer, Sharon Hancart, Tinne Lernout, Mathias Dewatripont, Lode Godderis, Geert Molenberghs
Confirmed COVID-19 Cases per Economic Activity during Autumn Wave in Belgium. International journal of environmental research and public health 18 (23) (2021)
Johan Verbeeck, Christel Faes, Thomas Neyens, Niel Hens, Geert Verbeke, Patrick Deboosere, Geert Molenberghs
A linear mixed model to estimate COVID-19-induced excess mortality. Biometrics (2021)
Gaohong Dong, Bo Huang, Duolao Wang, Johan Verbeeck, Jiuzhou Wang, David C Hoaglin
Adjusting win statistics for dependent censoring. Pharmaceutical statistics 20 (3) (2020)
Binbin Chen, Nicolas Gauquelin, Daen Jannis, Daniel M Cunha, Ufuk Halisdemir, Cinthia Piamonteze, Jin Hong Lee, Jamal Belhadi, Felix Eltes, Stefan Abel, Zoran Jovanović, Matjaž Spreitzer, Jean Fompeyrine, Johan Verbeeck, Manuel Bibes, Mark Huijben, Guus Rijnders, Gertjan Koster
Strain-Engineered Metal-to-Insulator Transition and Orbital Polarization in Nickelate Superlattices Integrated on Silicon. Advanced materials (Deerfield Beach, Fla.) 32 (50) (2020)
Johan Verbeeck, Vaiva Deltuvaite-Thomas, Ben Berckmoes, Tomasz Burzykowski, Marc Aerts, Olivier Thas, Marc Buyse, Geert Molenberghs
Unbiasedness and efficiency of non-parametric and UMVUE estimators of the probabilistic index and related statistics. Statistical methods in medical research 30 (3) (2020)
Johan Verbeeck, E Spitzer, T de Vries, G A van Es, W N Anderson, N M Van Mieghem, M B Leon, Geert Molenberghs, J Tijssen
Generalized pairwise comparison methods to analyze (non)prioritized composite endpoints. Statistics in medicine 38 (30) (2019)